XTX Topco Ltd lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 94.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 339 shares of the biotechnology company's stock after selling 5,311 shares during the quarter. XTX Topco Ltd's holdings in Axon Enterprise were worth $201,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in AXON. New Wave Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at $40,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise during the fourth quarter worth approximately $45,000. Stonebridge Financial Group LLC bought a new stake in Axon Enterprise during the 4th quarter worth approximately $53,000. GPS Wealth Strategies Group LLC increased its holdings in Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock valued at $56,000 after purchasing an additional 40 shares in the last quarter. Finally, Versant Capital Management Inc raised its position in Axon Enterprise by 4,750.0% in the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock valued at $58,000 after purchasing an additional 95 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.
Analysts Set New Price Targets
AXON has been the topic of a number of research analyst reports. Needham & Company LLC reissued a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, April 23rd. TD Cowen initiated coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. Finally, JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $626.45.
View Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Trading Up 1.2 %
AXON traded up $7.66 during mid-day trading on Friday, hitting $628.76. The stock had a trading volume of 120,211 shares, compared to its average volume of 753,622. The stock's fifty day simple moving average is $551.54 and its 200-day simple moving average is $575.64. The firm has a market capitalization of $48.95 billion, a price-to-earnings ratio of 162.47, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.
Insider Activity
In other news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This represents a 0.33 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company's stock, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by company insiders.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.